Nutex Health (NUTX) Change in Receivables (2011 - 2026)

Nutex Health has disclosed Change in Receivables across 16 years of filings, most recently posting $20.1 million for Q1 2026.

• Change in Receivables for Q1 2026 came in at $20.1 million, up 2967.07% year-over-year; the trailing twelve-month figure through Mar 2026 was $21.8 million (down 87.49% YoY), and the FY2025 annual result was $2.4 million, down 98.63% from the prior year.
• Change in Receivables came in at $20.1 million for Q1 2026 at Nutex Health, up from -$152.6 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $169.7 million in Q4 2024 to a low of -$152.6 million in Q4 2025.
• The 5-year median for Change in Receivables is $656000.0 (2025), against an average of $8.4 million.
• Across the five-year window, Change in Receivables slumped 30079.22% in 2022 and jumped 61900.0% in 2024, its largest moves.
• Nutex Health's Change in Receivables stood at -$54.8 million in 2022, then surged by 104.86% to $2.7 million in 2023, then surged by 6268.85% to $169.7 million in 2024, then sank by 189.91% to -$152.6 million in 2025, then surged by 113.19% to $20.1 million in 2026.
• The last three Change in Receivables figures came in at $20.1 million (Q1 2026), -$152.6 million (Q4 2025), and $152.8 million (Q3 2025), per Business Quant data.